Analyst firms · UBS · MDT

UBS MDT price target and rating history

Medtronic plc. (MDT) · Health Care

UBS rates Medtronic plc. (MDT) Buy with a $100 price target, as of its latest action on Jul 28, 2026. It has published 4 rating actions on MDT since August 2021, including 2 upgrades and 1 downgrade. Across 7 firms with a MDT price target in the last 12 months, the median target is $100. UBS's target matches it.

Current rating

Buy

Price target

$100

Median target, all firms

$100

Actions on MDT

4

UBS price target on MDT

Every UBS rating on MDT

• Jul 28, 2026
  UpgradeUBS upgrades to Buy from Neutral, price target $100
• Aug 15, 2024
  UpgradeUBS upgrades to Neutral from Sell, price target $76 to $90
• Mar 29, 2023
  DowngradeUBS downgrades to Sell from Buy, price target $127 to $79
• Aug 25, 2021
  ReiterateUBS raises its price target to $149 from $145, keeps Buy

How other firms rate MDT

Each firm's latest rating and stated target in the last 12 months.

Questions about UBS and MDT

What is UBS's price target for MDT?

UBS's latest stated price target for Medtronic plc. (MDT) is $100, from its action on Jul 28, 2026.

What is UBS's rating on MDT?

UBS rates MDT Buy, a bullish rating, as of Jul 28, 2026.

When did UBS last change its view on MDT?

On Jul 28, 2026, UBS upgrades to Buy from Neutral, price target $100.

How does UBS's MDT target compare with other analysts?

Across 7 firms with a MDT price target in the last 12 months, the median target is $100. UBS's target matches it.

More MDT rating histories

• Barclays3
• Needham7
• BTIG3
• Goldman Sachs4
• Citigroup6
• Wells Fargo6
• RBC Capital Markets3
• Oppenheimer4
• Morgan Stanley4
• Raymond James3
• Truist Securities3
• Credit Suisse3

All UBS ratingsMDT news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.